Highlights from our 2024-2025 financial statement.
Summary of consolidated expenses and financial position as of March 31st, 2025.
Program interventions – Year ended March 31, 2024 (in U.S. dollars)
| Vitamin A | $ 18,937,404 |
| Adolescents’ and Women’s Nutrition | $ 7,015,788 |
| Universal Salt Iodization | $ 2,712,544 |
| Zinc and ORS | $ 2,395,396 |
| Infant and Young Child Nutrition | $ 865,865 |
| Research and Quality Assurance | $ 4,024,849 |
| Maternal and Newborn Health and Nutrition | $ 7,781,854 |
| Global Advocacy | $ 2,060,439 |
| Food Fortification | $ 6,089,288 |
| Integrated Nutrition Programs | $ 6,019,929 |
| Technical Assistance Mechanism | $ 2,915,376 |
| Total | $ 60,818,732 |
Consolidated statement of financial position – March 31, 2025, with comparative information for 2024 (in U.S. dollars)
| Item | 2025 | 2024 | |
|---|---|---|---|
Assets |
|||
| Current Assets: | |||
| Cash | $ 53,905,054 | $ 12,509,101 | |
| Short-term Investments | 12,958,998 | 23,765,954 | |
| Accounts Receivable | 3,521,697 | 4,161,824 | |
| Prepaid Expenses | 1,225,320 | 1,279,591 | |
| Investments | 5,515,035 | 4,724,097 | |
| Tangible capital and intangible assets | 778,582 | 1,171,807 | |
| $ 77,904,686 | $ 47,612,374 | ||
Liabilities & Net Assets |
|||
| Current Liabilities: | |||
| Accounts payable and accrued liabilities | $ 8,151,166 | $ 4,942,690 | |
| Deferred contributions | 59,181,319 | 28,611,459 | |
| $ 67,332,485 | $ 33,554,149 | ||
| Net Assets: | |||
| Unrestricted | 12,121,105 | 14,299,421 | |
| Cumulative translation adjustment | (1,548,904) | (241,196) | |
| 10,572,201 | 14,058,225 | ||
| Commitments | |||
| $ 77,904,686 | $ 47,612,374 | ||